Skip to main content

Table 3 Comparison of patients with normal and reduced LVEF as measured by CMR

From: Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach

  All patients
n = 15
Patients with LVEF ≥ 60%
n = 5
Patients with LVEF <60%
n = 10
p value
LVEF [%] 52 (27 to 70) 65 (61 to 70) 42 (27 to 54) <0.001
Age [years] 37 (11 to 56) 14 (11 to 26) 42 (23 to 56) 0.004
BMI [kg/m 2 ] 23 (14 to 31) 19 (14 to 23) 23 (22 to 31) 0.048
LV-EDV [ml] 182 (94 to 230) 114 (94 to 212) 192 (129 to 230) 0.047
LV-mass [g] 117 (48 to 163) 70 (48 to 155) 119 (98 to 163) 0.047
LVEDD [mm] 52 (33 to 65) 46 (33 to 57) 55 (47 to 65) 0.09
RVEF [%] 56 (42 to 66) 65 (48 to 66) 54 (42 to 59) 0.10
RV-EDV [ml] 125 (104 to 213) 116 (104 to 213) 134 (104 to 180) 0.79
GWMS 0.19 (0 to 1.06) 0 0.34 (0 to 1.06) <0.001
LGE [%] 13.0 (0 to 38.0) 0 (0 to 13.0) 17.4 (0 to 38.0) 0.010
Total CK [U/L] 1532 (310 to 28194) 3668 (2570 to 28194) 602 (310 to 3609) 0.006
  1. Results are presented as median in addition to minimal and maximal values; LVEF = left ventricular ejection fraction; BMI = body mass index; LV-EDV = left ventricular end-diastolic volume; LVEDD = left ventricular end-diastolic diameter; RVEF = right ventricular ejection fraction; RV-EDV = right ventricular end-diastolic volume; GMWS = global wall motion score; LGE = late gadolinium enhancement; CK = creatinine kinase.